The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease

Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography

(2015) Elliot B Tapper et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases

(2015) Fabio Nascimbeni et al.   Clinical Gastroenterology and Hepatology

FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States Practice

(2015) Elliot B. Tapper et al.   Clinical Gastroenterology and Hepatology

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study

(2015) Nezam H. Afdhal et al.   Clinical Gastroenterology and Hepatology

Vibration-controlled transient elastography

(2015) Elliot B. Tapper et al.   CURRENT OPINION IN GASTROENTEROLOGY

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

(2015) Salvatore Petta et al.   HEPATOLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease

(2014) Salvatore Petta et al.   LIVER INTERNATIONAL

Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments

(2013) R. Kwok et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution

(2013) Umberto Arena et al.   HEPATOLOGY

Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

(2012) Vincent Wai-Sun Wong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Burden of Gastrointestinal Disease in the United States: 2012 Update

(2012) Anne F. Peery et al.   GASTROENTEROLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

(2011) S. Petta et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

(2011) Robert P. Myers et al.   HEPATOLOGY

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

(2010) J. K. Dowman et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999-2006

(2010) A. Mozumdar et al.   DIABETES CARE

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

(2010) S. McPherson et al.   GUT

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

(2008) Stephen A. Harrison et al.   HEPATOLOGY

Liver biopsy

(2008) Don C. Rockey et al.   HEPATOLOGY